Generic drugs saved the U.S. health care system $265.1 billion in 2017, according to the generic drug lobby's annual report released July 10. The group, the Association for Accessible Medicines, which titled this year's report “Access in Jeopardy,” laments being targeted by lawmakers writing drug pricing legislation, brands forestalling generic competition and purchasers consolidating, all of which, it argues, are making the market unsustainable. The Trump administration has lauded FDA's commitment to approving generic drugs, and a recent report authored...